XML 33 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share Based Payments (Tables)
9 Months Ended
Nov. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions used to Calculate Fair Value of Options on Date of Grant
The following assumptions were used to calculate the fair value of the Company’s options on the date of grant during the nine months ended November 30, 2014 and 2015:
 
 
Nine Months Ended November 30,
 
2014
 
2015
Risk-Free Interest Rate:
1.2% - 1.5%
 
1.3% - 1.4%
Expected Dividend Yield:
0%
 
0%
Expected Life (Years):
4.3
 
4.3
Expected Volatility:
69.0% - 73.9%
 
57.2% - 64.6%
Summary of Stock Options Outstanding and Activity
The following table presents a summary of the Company’s stock options outstanding at November 30, 2015, and stock option activity during the nine months ended November 30, 2015 (“Price” reflects the weighted average exercise price per share; "Aggregate Intrinsic Value" dollars in thousands):
 
 
Options
 
Price
 
Weighted Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
Outstanding, beginning of period
5,724,446

 
$
1.76

 
 
 
 
Granted
1,603,719

 
2.00

 
 
 
 
Exercised (1)
190,000

 
0.70

 
 
 
 
Forfeited
105,000

 
2.27

 
 
 
 
Expired
79,463

 
11.51

 
 
 
 
Outstanding, end of period
6,953,702

 
1.73

 
6.6
 
$
133

Exercisable, end of period
4,352,115

 
1.49

 
5.4
 
$
133


(1) 
Summary of Nonvested Options and Changes
A summary of the Company’s nonvested options at November 30, 2015, and changes during the nine months ended November 30, 2015, is presented below:
 
 
Options
 
Weighted Average
Grant Date
Fair Value
Nonvested, beginning of period
3,167,083

 
$
1.08

Granted
1,603,719

 
1.01

Vested
2,064,215

 
0.90

Forfeited
105,000

 
1.21

Nonvested, end of period
2,601,587

 
1.19

Summary of Restricted Stock Grants Outstanding and Activity
The following table presents a summary of the Company’s restricted stock grants outstanding at November 30, 2015, and restricted stock activity during the nine months ended November 30, 2015 (“Price” reflects the weighted average share price at the date of grant):
 
 
Awards
 
Price
Grants outstanding, beginning of period
677,634

 
$
2.26

Granted
2,374,687

 
1.25

Vested (restriction lapsed)
2,125,293

 
1.30

Forfeited
15,000

 
1.82

Grants outstanding, end of period
912,028

 
1.87

Stock-Based Compensation Expense and Related Tax Benefits Recognized
The following table summarizes stock-based compensation expense and related tax benefits recognized by the Company during the three months and nine months ended November 30, 2014 and 2015:
 
 
Three Months Ended November 30,
 
Nine Months Ended November 30,
 
2014
 
2015
 
2014
 
2015
Station operating expenses
$
83

 
$
365

 
$
553

 
$
1,610

Corporate expenses
514

 
539

 
1,575

 
3,059

Stock-based compensation expense included in operating expenses
597

 
904

 
2,128

 
4,669

Tax benefit
(300
)
 

 
(821
)
 

Recognized stock-based compensation expense, net of tax
$
297

 
$
904

 
$
1,307

 
$
4,669